2021
DOI: 10.1016/j.jcin.2021.05.015
|View full text |Cite
|
Sign up to set email alerts
|

Low-Flow, Low-Gradient Severe Aortic Stenosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Indeed, in the presence of a low transvalvular gradient at baseline or concomitant valvular disease, aortic valve replacement might be considered ineffective from an haemodynamic and prognostic standpoint [ 16 ]. On the other hand, conservative management of these patients has been associated with mortality rates 50% at 3-year follow-up while early post-operative mortality after SAVR reach up to 20% [ 17 , 18 ]. Thus, although current evidence is based only on observational studies, TAVI might be considered the optimal therapeutic option for patients with severe LFLG-AS [ 19 , 20 ].…”
Section: Valvular Heart Disease Treatment Devicesmentioning
confidence: 99%
“…Indeed, in the presence of a low transvalvular gradient at baseline or concomitant valvular disease, aortic valve replacement might be considered ineffective from an haemodynamic and prognostic standpoint [ 16 ]. On the other hand, conservative management of these patients has been associated with mortality rates 50% at 3-year follow-up while early post-operative mortality after SAVR reach up to 20% [ 17 , 18 ]. Thus, although current evidence is based only on observational studies, TAVI might be considered the optimal therapeutic option for patients with severe LFLG-AS [ 19 , 20 ].…”
Section: Valvular Heart Disease Treatment Devicesmentioning
confidence: 99%